Literature DB >> 8095102

Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.

U Broomé1, R Hultcrantz, A Scheynius.   

Abstract

In both primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) prominent infiltrates of lymphocytes surround the bile ducts, on which an abberrant expression of major histocompatibility complex class II antigens has been found, suggesting that the immune system is involved in the biliary destruction. Since the lymphocytes presumably must adhere to the bile ducts to initiate a cell-to-cell-mediated destruction, we have studied the expression of the lymphocyte function-associated antigen-1 (LFA-1) together with its ligand, the intercellular adhesion molecule-1 (ICAM-1), and the expression of HLA-DR, using immunoperoxidase staining of cryostat sections from patients with PBC (n = 10), PSC (n = 13), and normal healthy controls (n = 6). Most lymphocytes expressed LFA-1. ICAM-1 expression was found on hepatocytes from 9 of 10 PBC and 10 of 13 PSC patients but was not seen on hepatocytes from the controls. Hepatocytes expressing HLA-DR were only found in one patient with PBC. None of the septal bile ducts expressed ICAM-1, and only one PSC patient and three PBC patients expressed ICAM-1 on their interlobular bile ducts. The bile ducts in 22 of 23 patients, however, expressed HLA-DR. Proliferating bile ductules from two PBC patients and three PSC patients showed a concomitant expression of ICAM-1 and HLA-DR. None of the bile ducts from the controls expressed ICAM-1 or HLA-DR.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095102     DOI: 10.3109/00365529309096058

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  6 in total

1.  Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis: report of the overlapping of these two autoimmune diseases.

Authors:  K Tsuneyama; K Saito; B H Ruebner; I Konishi; Y Nakanuma; M E Gershwin
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

Review 2.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

3.  Proinflammatory cytokines and endotoxin stimulate ICAM-1 gene expression and secretion by normal human hepatocytes.

Authors:  S Satoh; A K Nüssler; Z Z Liu; A W Thomson
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

4.  Increased expression of intercellular adhesion molecules in biliary atresia.

Authors:  P Dillon; D Belchis; T Tracy; R Cilley; L Hafer; T Krummel
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

5.  Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.

Authors:  S Bloom; K Fleming; R Chapman
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

6.  Circulating intercellular adhesion molecule-1 (ICAM-1) in autoimmune liver disease and evidence for the production of ICAM-1 by cytokine-stimulated human hepatocytes.

Authors:  A W Thomson; S Satoh; A K Nüssler; K Tamura; J Woo; J Gavaler; D H van Thiel
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.